Cargando…

Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand

Head and neck cancer (HNC) accounts for more than 330,000 cancer deaths annually worldwide. Despite late diagnosis being a major factor contributing to HNC mortality, no satisfactory biomarkers exist for early disease detection. Cytoplasmic gelsolin (cGSN) was discovered to predict disease progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Chen-Tzu, Wang, Pei-Wen, Asare-Werehene, Meshach, Tsang, Benjamin K., Shieh, Dar-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353036/
https://www.ncbi.nlm.nih.gov/pubmed/32545773
http://dx.doi.org/10.3390/cancers12061569

Ejemplares similares